AU Patent

AU2009279473A1 — C7-fluoro substituted tetracycline compounds

Assigned to Tetraphase Pharmaceuticals Inc · Expires 2010-02-11 · 16y expired

What this patent protects

Patent listed against Xerava.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009279473A1
Jurisdiction
AU
Classification
—
Expires
2010-02-11
Drug substance claim
No
Drug product claim
No
Assignee
Tetraphase Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.